Get started
ELI LILLY AND COMPANYELI LILLY AND COMPANYELI LILLY AND COMPANY

ELI LILLY AND COMPANY

No trades
See on Supercharts
Overview
Financials News Ideas Discussions Technicals Forecast Seasonals Bonds

LLYCL chart


Full chart

Key facts today

Eli Lilly's Phase 3 study of tirzepatide showed nearly 99% of participants stayed diabetes-free after 176 weeks, with a 94% lower risk of type 2 diabetes and an average weight loss of 22.9%.
Eli Lilly and Company is assessing the competition in weight loss drugs, especially against Amgen's monthly drug MariTide, which differs from Eli Lilly's weekly injection schedule.
Analyze the impactAnalyze the impact

LLYCL upcoming earnings

Next report date
—
Report period
—
EPS estimate
—
Revenue estimate
—

Key stats


Market capitalization
‪780.88 T‬ CLP
Dividend yield (indicated)
0.64%
Price to earnings Ratio (TTM)
90.905
Basic EPS (TTM)
8,265.555 CLP
Net income (FY)
‪4.62 T‬ CLP
Revenue (FY)
‪30.09 T‬ CLP
Shares float
‪850.73 M‬
Beta (1Y)
0.90

Employees


Employees (FY)
‪43 K‬
Change (1Y)
‪+4 K‬ +10.26%
Revenue / Employee (1Y)
‪793.58 K‬ CLP
Net income / Employee (1Y)
‪121.87 K‬ CLP

About Eli Lilly and Company


Sector
Health Technology
CEO
David A. Ricks
Headquarters
Indianapolis
Website
lilly.com
Founded
1876
FIGI
BBG01NBMVZG8
Eli Lilly & Co. engages in the discovery, development, manufacture, and sale of pharmaceutical products. The firm's products consist of diabetes, oncology, immunology, neuroscience, and other products and therapies. The company was founded by Eli Lilly in May 1876 and is headquartered in Indianapolis, IN.

Financials


Performance
Revenue to profit conversion
Debt level and coverage
Earnings
Next:—
‪0.00‬

LLYCL news



Ideas



See all ideas 

Technicals

Summarizing what the indicators are suggesting.
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy

Analyst rating


An aggregate view of professional's ratings.
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy

Seasonals


Displays a symbol's price movements over previous years to identify recurring trends.

LLYCL highest yielding bonds


US532457AM0
ELI LILLY 2025
Yield to maturity
6.06%
Maturity date
Jun 1, 2025
LLY5871804
Eli Lilly and Company 5.2% 14-AUG-2064
Yield to maturity
5.40%
Maturity date
Aug 14, 2064
LLY4099975
Eli Lilly and Company 4.65% 15-JUN-2044
Yield to maturity
5.39%
Maturity date
Jun 15, 2044
LLY5750032
Eli Lilly and Company 5.1% 09-FEB-2064
Yield to maturity
5.37%
Maturity date
Feb 9, 2064
LLY5547405
Eli Lilly and Company 4.95% 27-FEB-2063
Yield to maturity
5.34%
Maturity date
Feb 27, 2063
US532457BS6
ELI LILLY 19/39
Yield to maturity
5.32%
Maturity date
Mar 15, 2039
LLY5871803
Eli Lilly and Company 5.05% 14-AUG-2054
Yield to maturity
5.32%
Maturity date
Aug 14, 2054
LLY5547404
Eli Lilly and Company 4.875% 27-FEB-2053
Yield to maturity
5.30%
Maturity date
Feb 27, 2053
LLY5750031
Eli Lilly and Company 5.0% 09-FEB-2054
Yield to maturity
5.24%
Maturity date
Feb 9, 2054
LLY.GG
Eli Lilly and Company 6.77% 01-JAN-2036
Yield to maturity
5.23%
Maturity date
Jan 1, 2036
US532457BU1
ELI LILLY 19/59
Yield to maturity
5.20%
Maturity date
Mar 15, 2059

Explore more bonds 

Sparks


Curated watchlists where LLYCL is featured.

See all sparks 

Frequently Asked Questions


The current price of LLYCL is 808,700.000 CLP — it has decreased by −2.26% in the past 24 hours. Watch ELI LILLY AND COMPANY stock price performance more closely on the chart.
Depending on the exchange, the stock ticker may vary. For instance, on BCS exchange ELI LILLY AND COMPANY stocks are traded under the ticker LLYCL.
LLYCL stock has risen by 4.14% compared to the previous week, the month change is a 1.89% rise, over the last year ELI LILLY AND COMPANY has showed a −5.85% decrease.
We've gathered analysts' opinions on ELI LILLY AND COMPANY future price: according to them, LLYCL price has a max estimate of 1,219,512.20 CLP and a min estimate of 682,926.83 CLP. Watch LLYCL chart and read a more detailed ELI LILLY AND COMPANY stock forecast: see what analysts think of ELI LILLY AND COMPANY and suggest that you do with its stocks.
LLYCL reached its all-time high on Aug 22, 2024 with the price of 878,500.000 CLP, and its all-time low was 726,200.000 CLP and was reached on Aug 7, 2024. View more price dynamics on LLYCL chart.
See other stocks reaching their highest and lowest prices.
LLYCL stock is 2.07% volatile and has beta coefficient of 0.90. Track ELI LILLY AND COMPANY stock price on the chart and check out the list of the most volatile stocks — is ELI LILLY AND COMPANY there?
Today ELI LILLY AND COMPANY has the market capitalization of ‪764.36 T‬, it has increased by 2.46% over the last week.
Yes, you can track ELI LILLY AND COMPANY financials in yearly and quarterly reports right on TradingView.
ELI LILLY AND COMPANY is going to release the next earnings report on Jan 30, 2025. Keep track of upcoming events with our Earnings Calendar.
LLYCL earnings for the last quarter are ‪1.06 K‬ CLP per share, whereas the estimation was ‪1.28 K‬ CLP resulting in a −16.97% surprise. The estimated earnings for the next quarter are ‪5.38 K‬ CLP per share. See more details about ELI LILLY AND COMPANY earnings.
ELI LILLY AND COMPANY revenue for the last quarter amounts to ‪10.31 T‬ CLP, despite the estimated figure of ‪10.91 T‬ CLP. In the next quarter, revenue is expected to reach ‪13.76 T‬ CLP.
LLYCL net income for the last quarter is ‪874.93 B‬ CLP, while the quarter before that showed ‪2.80 T‬ CLP of net income which accounts for −68.77% change. Track more ELI LILLY AND COMPANY financial stats to get the full picture.
Yes, LLYCL dividends are paid quarterly. The last dividend per share was ‪1.21 K‬ CLP. As of today, Dividend Yield (TTM)% is 0.61%. Tracking ELI LILLY AND COMPANY dividends might help you take more informed decisions.
ELI LILLY AND COMPANY dividend yield was 0.78% in 2023, and payout ratio reached 77.91%. The year before the numbers were 1.07% and 56.79% correspondingly. See high-dividend stocks and find more opportunities for your portfolio.
As of Nov 14, 2024, the company has ‪43.00 K‬ employees. See our rating of the largest employees — is ELI LILLY AND COMPANY on this list?
EBITDA measures a company's operating performance, its growth signifies an improvement in the efficiency of a company. ELI LILLY AND COMPANY EBITDA is ‪14.52 T‬ CLP, and current EBITDA margin is 34.73%. See more stats in ELI LILLY AND COMPANY financial statements.
Like other stocks, LLYCL shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade ELI LILLY AND COMPANY stock right from TradingView charts — choose your broker and connect to your account.